SCHEMBL695291

SCHEMBL695291

Cc1sccc1-c1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 11/20 0.51
MAPK14 Q16539 1/20 0.50
PTGS2 P35354 7/20 0.49
PRKCZ Q05513 1/20 0.40
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8089263 0.82 PTGS2 (0.49) PTGS1PTGS2ACHE
SCHEMBL5126984 0.78 KIF11 (0.42)
SCHEMBL1825367 0.77 BCAT2 (0.47) PTGS2PRKCZ
SCHEMBL7163500 0.76 PTGS1 (0.58) PTGS1MAPK14PTGS2
SCHEMBL693705 0.76 ACHE (0.42) ACHE
SCHEMBL10843937 0.76 MAPK14 (0.79) PTGS1MAPK14PTGS2
SCHEMBL16887409 0.75 PLA2G10 (0.40) PTGS2
SCHEMBL8038496 0.75 PTGS2 (0.51) PTGS1PTGS2ACHE
SCHEMBL7323658 0.74 MAPK14 (0.50) PTGS1MAPK14PTGS2
SCHEMBL9812737 0.74 MAPK14 (0.50) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed